FDA Brief

Company record

Lovely Meds, Inc. dba Lovely Meds

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Lovely Meds, Inc. dba Lovely Meds.

Warning letters

  1. Lovely Meds, Inc. dba Lovely Meds

    FDA cited Lovely Meds for misleading website claims that compounded semaglutide and tirzepatide are the same as FDA-approved drugs.

    Low